Despite newer TB drugs, delayed diagnosis, atypical symptoms and drug resistance continue to complicate treatment ...

A single daily pill shows promise as replacement for complex, multi-tablet HIV treatment regimens according to the findings of a new phase 3 clinical trial, published in The Lancet. The study was ...

Health workers in developing countries know that isolating tuberculosis patients is an outdated and potentially harmful practice, but lack the resources to move away from it. By Stephanie Nolen ...

BUFFALO, N.Y. – Researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new inhalable form of tuberculosis (TB) treatment that could ...

As therapies and antibiotics develop and improve, pathogens adapt to overcome current medications. Bacteria are a specific organism that can adapt quickly to resist antibiotic treatment due to rapid ...

Xpert MTB/RIF Ultra is a rapid test that probably reduces the time taken to diagnose tuberculosis (TB) and the time from diagnosis to starting treatment. Using Xpert MTB/RIF Ultra does not reduce ...

Oxford Nanopore Technologies plc and Biomérieux SA launched Ampore-TB, a research use only test that can rapidly detect mutations linked to antimicrobial resistance in tuberculosis. With ...

A new report from the Centers for Disease Control and Prevention on the deadly drug-resistant bacteria NDM-CRE found a 70% rise in infections in the U.S. between 2019 and 2023. Also known as ...

Tuberculosis (TB) cases in England increased by 13.6% in 2024 compared with the previous year, according to new data from the UK Health Security Agency (UKHSA). There were 5490 TB notifications in ...

Vietnamese doctor Truong Duc Thai and a colleague check the X-ray film of a drug-resistant tuberculosis patient at National Lung Hospital in Hanoi. TB kills more people than any other infectious ...